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Background: To evaluate usability of slice-reduced sequential computed tomography (CT) compared to 
standard high-resolution CT (HRCT) in patients with systemic sclerosis (SSc) for qualitative and quantitative 
assessment of interstitial lung disease (ILD) with respect to (I) detection of lung parenchymal abnormalities, 
(II) qualitative and semiquantitative visual assessment, (III) quantification of ILD by histograms and (IV) 
accuracy for the 20%-cut off discrimination. 
Methods: From standard chest HRCT of 60 SSc patients sequential 9-slice-computed tomography (reduced 
HRCT) was retrospectively reconstructed. ILD was assessed by visual scoring and quantitative histogram 
parameters. Results from standard and reduced HRCT were compared using non-parametric tests and 
analysed by univariate linear regression analyses.
Results: With respect to the detection of parenchymal abnormalities, only the detection of intrapulmonary 
bronchiectasis was significantly lower in reduced HRCT compared to standard HRCT (P=0.039). No 
differences were found comparing visual scores for fibrosis severity and extension from standard and reduced 
HRCT (P=0.051–0.073). All scores correlated significantly (P<0.001) to histogram parameters derived from 
both, standard and reduced HRCT. Significant higher values of kurtosis and skewness for reduced HRCT 
were found (both P<0.001). In contrast to standard HRCT histogram parameters from reduced HRCT 
showed significant discrimination at cut-off 20% fibrosis (sensitivity 88% kurtosis and skewness; specificity 
81% kurtosis and 86% skewness; cut-off kurtosis ≤26, cut-off skewness ≤4; both P<0.001). 
Conclusions: Reduced HRCT is a robust method to assess lung fibrosis in SSc with minimal radiation dose 
with no difference in scoring assessment of lung fibrosis severity and extension in comparison to standard HRCT. 
In contrast to standard HRCT histogram parameters derived from the approach of reduced HRCT could 
discriminate at a threshold of 20% lung fibrosis with high sensitivity and specificity. Hence it might be used to 
detect early disease progression of lung fibrosis in context of monitoring and treatment of SSc patients.
Keywords: Interstitial lung disease (ILD); reduced high-resolution computed tomography of the lung (reduced 
HRCT of the lung); histogram parameters from reduced high-resolution computed tomography (histogram 
parameters from reduced HRCT); systemic sclerosis (SSc)
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Introduction
Pulmonary involvement occurs often in systemic sclerosis 
(SSc) and is now the leading cause of mortality in SSc 
patients (1). An autopsy-study showed parenchymal lung 
abnormalities in up to 80% of SSc patients (2). Pulmonary 
function tests are considered the gold standard for the 
screening of parenchymal lung involvement. However, 
because lung function tests as well as chest X-ray tend to be 
insensitive to detect early lung involvement, high-resolution 
computed tomography (HRCT) plays an important role in 
the detection and characterization of interstitial lung disease 
(ILD) in patients with SSc (3-8). 
According to Lynch and Best, the visual extent of 
fibrosis on computed tomography (CT) images is the 
strongest independent predictor of mortality in patients 
with idiopathic pulmonary fibrosis (IPF) (5,9). Additionally, 
Hoffmann-Vold et al. showed that HRCT performed at 
baseline in SSc patients can predict the development of 
fibrosis (10). Different studies have shown that the extent 
and severity of ILD can be adequately assessed using visual 
scales (3,6,8). Further the extension of fibrosis is evidently 
associated with an increased risk of death (11-13).
During the last decade, several studies evaluated the value 
of quantitative assessment of ILDs. Especially the skewness 
(describes the extent of asymmetry of histograms) and the 
kurtosis (describes how sharply peaked a histogram is) 
of the Hounsfield unit (HU) histogram derived from CT 
showed a strong correlation with the visual assessment 
of lung involvement (14). Quantitative assessment of 
fibrosis is a proven robust method with the advantage of 
standardization and of being more objective and reader-
independent (14-17). HRCT has the capability (I) to early 
detect ILD, (II) to quantify the extent of ILD, and (III) to 
monitor treatment and disease progression (8,18-22). 
Because HRCT adds important information in the 
diagnostic evaluation of patients with suspected ILD, 
guidelines for the evaluation with HRCT have been 
developed (5). However, the use of CT for screening 
and follow-up has to be considered carefully due to the 
accumulating radiation dose with an increase of the risk 
of cancer (23-25). For daily routine, a method has to 
be found and validated that balances between the high 
diagnostic sensitivity of CT and the radiation dose (1,24,26). 
Sverzellati et al. could show that low-dose spiral CT with 
reduced milliampere (mA) allows successful quantitative 
evaluation of lung fibrosis in patients with idiopathic 
interstitial pneumonitis (16). Pontana et al. could show, that 
with a dose reduction of 60%, CT images reconstructed 
with sinogramm-affirmed iterative reconstruction (SAFIRE) 
still allow a similar detection of ILD in SSc patients (27). 
Besides different scan parameter based dose modulations, 
reduction of scan range or number of images per scan can 
also lead to a significant dose reduction maintaining the 
high diagnostic sensitivity (16,28). 
An alternative strategy is the reduction of scan range 
or the number of slices by applying a sequential mode. A 
former prospective study by Winklehner et al. showed that 
the use of a dedicated HRCT based on reduced sequential 
slices throughout the entire chest can detect lung fibrosis 
with a high diagnostic sensitivity and accuracy of both 94% 
with a very low radiation dose (28). Similar strategies with 
the aim of dose reduction in CT for other indications have 
also been performed by Bankier et al. and de Jong et al. 
(29,30). The advantage of a low sampling protocol is the 
very low radiation dose of less than 0.028 mSv, which is in 
the range of a chest X-ray (28). Further Frauenfelder et al. 
could confirm in a retrospective image analysis that by the 
approach of using a sequential reduced 9-slice HRCT mild 
ILD can reliably be detected with the advantage of a much 
lower radiation dose (31). 
To date the differences between a sequential reduced 
sliced HRCT and standard HRCT in context of assessment 
of lung fibrosis and the quantitative histogram-based 
approach has not been evaluated in detail.
The aim of this study was to retrospectively evaluate the 
usability of slice-reduced sequential CT [further named 
reconstructed sequential 9-slice-computed tomography 
(reduced HRCT)] compared to standard HRCT in patients 
with SSc with respect to (I) detection of lung parenchymal 
abnormalities, (II) qualitative and semiquantitative visual 
assessment, (III) quantification of ILD by histograms 
and (IV) accuracy for the threshold of 20% lung fibrosis 
discrimination. 
Methods
Study population
S i x t y  p a t i e n t s  [ m e d i a n  a g e  6 1 . 5  y e a r s  ( r a n g e , 
28–77 years), 44 females, 16 males] were included for this 
study with the following inclusion-criteria: All patients 
fulfilled the very early diagnosis of SSc (VEDOSS) 
and/or the American College of Rheumatology (ACR) 
classification criteria for SSc (32-34). All patients underwent 
HRCT during a standardized assessment program, 
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which also included clinical examination, lung function 
tests, echocardiography and laboratory analysis based 
on European Scleroderma Trials and Research group 
(EUSTAR) recommendations (32). Of the enrolled patients, 
33 had limited SSc and 27 patients had diffuse SSc based on 
the LeRoy criteria (4). Patient recruitment and assessment 
of clinical parameters was performed prospectively, the 
image analysis retrospectively. The study was approved as 
part of the SSc registry by the local ethical committee. All 
patients signed informed consent. 
CT protocol for standard HRCT and reconstruction of 
reduced HRCT 
All CT-images were acquired in prone position in 
full inspiration. CT scans were performed with two 
types of scanners: 128 slice multidetector CT scanner 
(Somatom Flash, Siemens, Erlangen, Germany) and 
64 slice multidetector CT scanner (Somatom AS, Siemens, 
Erlangen, Germany). The CT protocol included a 
topogram and one serie in prone position. The following 
parameters were used for the standard-HRCT: Tube 
voltage 120 kV, tube current 30 mAs (reference dose, care 
dose: on), slice thickness: 1 mm, increment: 0.8 mm, kernel 
B30 and B70. The standard HRCT was reconstructed with 
iterative reconstruction (SAFIRE) strength 3 and 5. Using 
the standard HRCT dataset a 9-slice-CT (further named 
reduced HRCT) was reconstructed as following: nine 
axial slices with an apico-basal gradient, whereas the first 
three slices had an increment of about 80 mm (first slice: 
manubrium sterni, second slice: hilum, third slice: level of 
lower lobe, based on increment between first and second 
slice); for the following 6 slices the increment was 15 mm 
(covering the lung basis) (28). To simulate the reproducibility 
of reduced HRCT retrospectively in a possible prospective 
setting, in a subgroup of 20 patients slightly different 
9 slices with a systematic distance difference within a 
range of 1–3 cm in comparison to the aforementioned 
standardized slice levels but with the same defined 
increment between the slices within the same specimen was 
reconstructed.
Radiation dose estimation
One patient was scanned with the aforementioned 
standardized reduced 9 slices (reduced HRCT) series to 
estimate the radiation dose reduction compared to standard 
HRCT (35). 
Visual analysis
A l l  s t a n d a r d  H R C T  a n d  r e d u c e d  H R C T  w e r e 
independently assessed by two radiologists (TF, 12 years 
of experience; BD, 5 years of experience) on a PACS 
workstation (Impax, AGFA, Dübendorf, Switzerland) 
with a fixed window/level setting (window: 1,600 HU, 
level: −600 HU). 
The visual analysis included the assessment of severity 
(qualitative assessment) and extension (semiquantitative 
assessment) ,  based on previous publicat ions:  the 
severity score is based on definition of five parenchymal 
abnormalities assumed to reflect the increasing severity 
of lung involvement. It ranges from 0 to 15 and has 
been adapted from Camiciottoli et al. (14): ground-glass 
appearance (score 1), irregular pleural margins (score 2), 
septal and subpleural lines (score 3), honeycombing 
(score 4), and subpleural cysts (score 5) (Table S1). 
The extension score was adapted from Goldin 
et al. (3): each lung was divided into three zones: upper 
zone (from apex to upper level of carina), middle zone 
(from upper part of carina to division of main lower 
lobe bronchus into segmental bronchi) and lower zone 
(from the division of main lower lobe bronchus into 
segmental bronchi to the basis of the lung). Each zone 
was evaluated using a scale from 0 to 4 (0 to 4; 0, no 
fibrosis, 4, >75% of fibrosis) (Table S2). Additionally, the 
sum of both scores (the severity and extension score) was 
calculated, further named total score. In order to prevent 
a recall-bias an interval of 1 month was set between both 
readouts. 
Quantitative analysis
The lung density histogram parameters including 
mean lung attenuation (mean HU derived from lung 
segmentation), kurtosis and skewness were calculated 
from the standard HRCT and the reduced HRCT, 
us ing dedicated commercia l ly  avai lable  software 
(myrian, intrasense, France). The kurtosis is a value 
for sharpness of histogram peak. A lower value means 
a more platykurtic (flat and lower) curve with a more 
homogenous distribution of the histogram parameters. 
The skewness is a value for asymmetry of distribution in 
HU-histogram. A higher value means a more asymmetric 
distribution, whereas a positive value represents a 
positively skewed or left-skewed distribution (distribution 
towards higher HU-values). 
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Visual and quantitative analysis in reduced HRCT with 
slightly different chosen 9 slices
The visual analysis as well as the quantitative analysis as 
described in the last two passages were also performed for 
the reduced HRCT with slightly different chosen 9 slices 
and compared to the reduced HRCT as well as to the 
standard HRCT. 
Statistics
For statistical analysis, SPSS Version 22 was used. The 
McNemar-test was applied to compare the qualitative 
assessment of the parenchymal lung abnormalities. 
Univariate linear regression analyses were used to correlate 
the relationship of histogram parameters with the severity 
score, the extension score and the total score. Based on the 
results of Goh et al. (12,36) showing that a threshold of 20% 
fibrosis on CT scan provides a discriminatory prognostic 
information, two groups were built [group 1 (≤20% 
fibrosis), group 2 (>20% fibrosis)]. The formation of group 
1 and group 2 was based on the fibrosis extension score 
(Table S2). These groups were correlated with the kurtosis and 
skewness by regression analyses (12). Interreader agreement 
for visual assessment was calculated by Krippendorff’s alpha 
(perfect reliability α=1.00, good reliability α>0.800, acceptable 
>0.667, absence of reliability α=0.000) (37-39). P values <0.05 
were considered statistically significant.
Results
Patient characteristics
The clinical characteristics of the 60 patients recruited for 
the study are summarized in Table 1 (40,41). In 31 patients 
≤20% lung fibrosis was found, in 29 patients fibrotic lung 
involvement was >20%.
Radiation dose estimation
The estimated effective radiation dose for the reduced 
HRCT was 0.041 mSv (equivalent to a dose reduction of 
97.4%, standard of reference 1.6 mSv). 
Detection of lung pattern abnormalities: standard HRCT 
versus reduced HRCT
 
The overall detection rate of parenchymal abnormalities 
did not significantly differ between standard and reduced 
HRCT (P=0.063–1.0) with exception of bronchiectasis, 
which were detected at a significantly lower rate on reduced 
HRCT (P=0.039) (Table 2). The interreader variability was 
acceptable to good (Krippendorf’s α=0.68–0.92).
Qualitative and semiquantitative assessment score: 
standard HRCT versus reduced HRCT
The qualitative and semiquantitative assessments showed no 
significant difference between standard HRCT and reduced 
HRCT (P=0.051–0.06) but with a trend to a higher severity 
score and total score in the reduced HRCT (Table 3). 
Correlation of fibrosis assessment scores with histogram 
parameters 
The visually assessed severity score, extension score and 
total score correlated significantly (P<0.001) with the 
Table 1 Clinical characteristics
Items Clinical characteristics
Age (years), mean ± SD 58±13
Sex (n) Male (n=16), female (n=44)
Disease duration (months), 
median (range)
81 (10–564)
Disease subsets (n) lSSc (n=33), dSSc (n=27)
Extent of skin fibrosis 
assessed by the modified 
Rodnan Skin score,  
median (range)/51
9.5 (0–31)/51
Antibody profile (n) ANA positive (n=59)  
ACA positive (n=16)  
Scl-70 positive (n=23)  
RNA-polymerase III positive 
(n=7)
Major organ involvement 
except lung fibrosis ± (n)
Heart (n=18)  
Gastrointestinal tract (n=10)  
Pulmonary arterial hypertension 
(n=5)
Lung function parameters, mean ± SD (range) 
FVC (%) predicted 92.49±22.1 (41–136)
FEV1 (%) predicted 89.76±19.74 (42–122.2)
TLC (%) predicted 90.74±2.83 (31.1–139)
DCLO (%) predicted 76.32±19.3 (40–123)
2146
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2018;10(4):2142-2152jtd.amegroups.com
Nguyen-Kim et al. Lung fibrosis assessment on slice-reduced CT
skewness and kurtosis for reduced and standard HRCT 
(reduced HRCT—kurtosis: r=0.50–0.54, skewness: 
r=0.50–0.56; whole-chest-CT—kurtosis: r=0.48–0.54, 
skewness: r=0.49–0.57). 
Figure 1 demonstrates a representative example of the two 
different curves derived from the histogram parameters from 
the standard HRCT and reduced HRCT within the same 
patient.
Histogram parameters: standard HRCT versus reduced 
HRCT
Reduced HRCT revealed significant higher values for mean 
kurtosis and skewness in comparison to standard HRCT (for 
both P<0.001, Table 4). 
Histogram parameters in correlation with prognostic 
factors in SSc patients
For standard HRCT no significant difference was found for 
the 20%-cutoff (P=0.053 for kurtosis, P=0.061 for skewness) 
(Figure 2A), comparing the histogram parameters between 
group 1 (≤20% fibrosis) and group 2 (>20% fibrosis). For 
reduced HRCT a differentiation between group 1 (≤20% 
fibrosis) and group 2 (>20% fibrosis) was seen with a 
sensitivity of 88% for kurtosis and skewness and a specificity 
of 81% for kurtosis and 86% for skewness (cut-off point 
kurtosis ≤26, cut-off point skewness ≤4) (P<0.001 for both, 
kurtosis and skewness) (Figure 2B). The positive predictive 
values (PPVs) were 62% for both and the negative predictive 
values (NPVs) were 80% and 78% for kurtosis and skewness. 
Association of lung function parameter with histogram 
parameters
Forced vital capacity (FVC) correlated significantly (for 
both P<0.001) with the skewness and kurtosis for reduced 
and standard HRCT (reduced HRCT—kurtosis: R=0.48, 
skewness: R=0.53; whole-chest-CT—kurtosis: R=0.41, 
skewness: R=0.40). 
Visual and quantitative analysis in reduced HRCT with 
slightly different chosen 9 slices versus standardized 
reduced HRCT
Comparing the reduced HRCT with slightly different 
Table 2 Detection of lung patterns in the standard HRCT versus reduced HRCT
Lung pattern
Patients with abnormality
Standard HRCT (n, %) Reduced HRCT (n, %) P value
Ground-glass 15 (25%) 11 (18.3%) 1.000
Pleural margins 39 (65%) 35 (58.3%) 0.125
Subpleural lines 42 (70%) 40 (66.7%) 1.000
Honeycombing 10 (16.7%) 7 (11.7%) 0.063
Emphysema 3 (5%) 2 (3.3%) 0.500
Bronchiectasis 23 (38.3%) 12 (20%) 0.039
HRCT, high-resolution computed tomography.
Table 3 Qualitative and semiquantitative assessment scores derived from standard HRCT and from reduced HRCT
Assessment score 
Standard HRCT Reduced HRCT 
P value
Mean SD Range Mean SD Range
Severity score (qualitative assessment) 4.68 3.49 0–15 5.23 4.28 0–18 0.051
Extension score (semiquantitative assessment) 4.99 5.28 0–19 4.83 5.02 0–21 0.073
Total score (summary score of severity score and 
extension score)
9.61 7.93 0–25 10.36 8.67 0–26 0.060
HRCT, high-resolution computed tomography; SD, standard deviation.
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chosen 9 slices to the standardized reduced HRCT, no 
significant difference was seen in the detection of lung 
patterns (P>0.871), as well as for qualitative assessment 
of the severity score (mean 4.98 ± SD 4.32 versus mean 
5.23 ± SD 4.28; P=0.615), semiquantitative assessment 
of the extension score (mean 4.78 ± SD 4.95 versus mean 
4.83 ± SD 5.02; P=0.086), and the total score (mean 10.05 ± 
SD 9.07 versus mean 10.36 ± SD 8.67; P=0.071).
No significant difference was observed comparing the 
reduced HRCT with slightly different chosen 9 slices 
to standardized reduced HRCT for the severity score 
(P=0.067), the extension score (P=0.081), and the total score 
(P=0.057). 
The histogram parameters derived from the reduced 
HRCT with slightly different chosen 9 slices also did 
not differ significantly in comparison to the standardized 
reduced HRCT (kurtosis: mean 21.6 ± SD 9.14 versus mean 
22.4 ± SD 8.66; P=0.074 and skewness: mean 3.7 ± SD 
1.84 versus 3.63 ± SD 0.94; P=0.067). Also the histogram 
parameters derived from the reduced HRCT with slightly 
different chosen 9 slices where significantly higher in 
comparison to whole standard HRCT (Kurtosis: 21.6 ± SD 
Figure 1 Curve derived from the histogram parameters from the CT of the same patient by (A) standard HRCT chest-CT and (B) 
reduced HRCT demonstrating the change in the skewness and the kurtosis. CT, computed tomography; HRCT, high-resolution computed 
tomography.
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9.14 versus 12.5 ± SD 7.12, Skewness: mean 3.71 ± SD 1.84 
versus 2.58 ± SD 0.9; P<0.001 for both).
Discussion
This study aimed to assess whether such a dedicated CT 
as the reduced HRCT with minimal dose can be used for 
qualitative and quantitative assessment of lung involvement 
in SSc patients, with special focus on visual assessment and 
the histogram-based approach in comparison to standard 
HRCT.
With respect  to the detect ion of  parenchymal 
Figure 2 Histogram parameters in correlation with 20%-cutoff lung fibrosis as a prognostic factor in SSc patients. (A) Kurtosis and skewness 
of standard HRCT compared to the extend of 20% fibrosis [group 1: ≤20% fibrosis (n=31), group 2: >20% fibrosis (n=29)]; (B) Kurtosis and 
skewness of reduced HRCT compared to the extent of 20% fibrosis [group 1: ≤20% fibrosis (n=31), group 2: >20% fibrosis (n=29)]. HRCT, 
high-resolution computed tomography.
Table 4 Histogram parameters derived from standard HRCT and from reduced HRCT
Assessment score
Standard HRCT Reduced HRCT
P value
Mean SD Range Mean SD Range
Kurtosis 12.50 7.12 2.95–40.85 22.4 8.66 4.73–47.53 <0.001
Skewness 2.58 0.9 0.85–4.80 3.63 0.94 1.34–5.47 <0.001
HRCT, high-resolution computed tomography; SD, standard deviation.
Fibrosis ≤20% Fibrosis ≤20%
P<0.001 P<0.001
Kurtosis Skewness
Fibrosis >20% Fibrosis >20%
50.00
40.00
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P=0.053 P=0.061
Kurtosis Skewness30.00
25.00
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15.00
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5.00
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2.00
1.00
0.00
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abnormalities, only the detection of intrapulmonary 
bronchiectasis was significantly lower in the reduced HRCT 
compared to standard HRCT. This finding may have been 
caused by the use of the small limited number of thin 
sliced sequential CT images, as even on standard HRCT 
the distinguishing of cystic change as honeycombing 
from bronchiectasis can be difficult (42). Since it is known 
that traction bronchiectasis is commonly associated with 
advanced fibrotic changes (43,44) and correlates with the 
amount of fibrosis (45), it can be assumed, that its detection 
rate may not influence the overall fibrosis assessment 
compared to other findings of advanced fibrosis such as 
honeycombing, coarse reticular pattern, and architectural 
distortion (43,44). 
On the other hand, despite the difference in detection 
of bronchiectasis no difference in the qualitative and 
semiquantitative assessment of fibrosis scoring comparing 
standard and reduced HRCT was seen. Takei et al. could 
demonstrate in confirmation of known evidence (11,12) 
that a high fibrosis extension score is associated with an 
increased risk of death, and further independent from 
HRCT pattern (13). In this context reduced HRCT might 
qualify for the visual scoring of lung fibrosis extension as 
no difference to standard HRCT was found and could be 
used as a follow-up examination in monitoring and therapy 
management of patients with SSc-ILD. 
However, the reduced HRCT might miss other lung 
pathologies, as for example lung cancer. Because the aim 
of this type of CT protocol is detection and quantification 
of SSc-ILD and not early lung cancer detection, a whole-
chest-CT examination at baseline should be recommended 
to capture incidental intra-parenchymal lesions that might 
need further follow up. However, in younger patients 
with expected longer span of life follow up examinations 
additionally whole-chest CT examinations in bigger time 
intervals should be considered. 
Our results show that quantitative histogram parameters 
derived from a dedicated reduced HRCT were significantly 
higher compared to standard HRCT of the whole lung. 
This finding can be explained by the defined distribution 
of the slices for the reduced HRCT. By selection of a 
disproportionally higher number of slices at the lung 
base, the known less affected parts of the lung for ILD in 
SSc patients are systematically excluded. This leads to a 
disproportionate higher evaluation of the affected areas 
in comparison to the histogram parameters derived from 
standard HRCT which include also the complete volume of 
the healthy not affected lung. Especially in early stage SSc 
patients with only discrete fibrotic intrapulmonary patterns 
in the lung base such a dedicated reduced HRCT can 
provide augmented histogram parameters, in which even 
discreet dynamic changes of fibrotic lung involvement may 
be represented.
Although histogram parameters derived from both 
reduced and standard HRCT correlated with the 
corresponding visual assessment scores for fibrosis 
severity and extension with no significant difference, only 
for the histogram parameters from reduced HRCT a 
discrimination at a threshold of 20% fibrosis was found 
with a high sensitivity of 88% for kurtosis and skewness 
and a specificity of 81% for skewness and 86% for kurtosis 
resulting in good NPVs of 78–80% and a moderate PPVs 
of 62%. Following this approach of a reduced HRCT with 
focused apico-basal gradient we believe, that in particularly 
subtle changes for example in ground glass pattern may 
be earlier quantitatively detected especially in early stage 
SSc patients during follow up examinations, which even an 
experienced radiologic eye possibly could miss. Particularly 
in SSc patients with rapid disease progression one 
important key parameter is to detect increasing ILD at the 
earliest time point as possible, and not the general detection 
of ILD alone, because in this situation immediately 
progressive treatment initiation is recommended by the 
experts (10,46). In this context Mendoza et al. even 
recommend the performance of standard HRCT every 
6–8 months for the first 2 years after time point of 
diagnosis (46), assuming a higher benefit for the patient in 
case of early detection of disease progression compared to 
radiation dose protection.
Therefore, the reduced HRCT may represent a powerful 
tool that not only allows to visualize early ILD in SSc as 
shown recently (28,31), but may also be a tool to quantify 
subtle new fibrotic changes in lung parenchyma during 
follow up, especially with a significantly lower radiation 
exposure with a 97.4% reduction of estimated effective 
radiation dose in our cohort with 0.041 mSv which is in a 
range of a conventional chest X-ray and can be considered 
as a screening method for early detection and early 
evaluation of SSc ILD increase, rather than detection of 
lung fibrosis alone. 
Although FVC correlated significantly with the 
histogram parameters of standard and reduced HRCT 
no cut off value for the 20% lung fibrosis was found. The 
reason therefore might be differences in population, as most 
of our cases had early SSc, which are not visible within the 
limitations of pulmonary function. This concludes that the 
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histogram parameters, derived from the reduced HRCT, 
might be a more robust marker in the assessment of fibrosis 
in early SSc patients than the clinical parameter FVC, 
derived from spirometry. The latter has several limitations: 
it is related to patient’s motivation, and has a low sensitivity, 
and therefore can be normal in case of known minor 
fibrotic pulmonary changes (17). This was confirmed in a 
previous study in which high rates of false-negative results 
in pulmonary function tests in the early detection of ILD 
screening in SSc patients was observed (7). 
Our study has certain limitations: 
(I) The major limitation is that we retrospectively 
reconstructed the reduced HRCT from the 
standard HRCT and therefore have no technical 
obstacles, which may occur when performing such 
a CT protocol prospectively. We tried to simulate 
the reproducibility of the results derived from the 
reduced HRCT for both, the visual analysis as 
well as the quantitative analysis by retrospectively 
simulating slightly different slices for the reduced 
HRCT but with the same increment levels to 
simulate different inspiration depths. Although we 
could show no significant differences between the 
retrospectively standardized reconstructed reduced 
HRCT and the reduced HRCT with slightly 
different slices in our cohort, our study still faces 
the limitation of possible breathing artefacts during 
the examination or overlying of other diseases such 
as infection or pulmonary congestion. In case of new 
observed overlying disease, we would recommend 
comparison of reduced HRCT with recent imaging 
if available in combination with further clinical 
examination including additional imaging examination 
if needed to achieve an appropriate diagnosis for 
optimal patient treatment. After successful therapy 
a repetition of reduced HRCT for monitoring of 
ILD can be considered. An ongoing study will assess 
the accuracy and robustness of this CT-protocol for 
follow-up examination of fibrotic changes in the lung 
in SSc patients. 
(II) With the concept of reduced HRCT the detection 
rate of bronchiectasis was low, which possibly could 
be explained, that with the use of a small limited 
number of thin sliced sequential CT images the 
known difficulties of differentiating bronchiectasis 
from honeycombing might have been accentuated. 
Since bronchiectasis is an intraparenchymal pattern 
associated with advanced fibrotic changes, we 
believe that our approach of reduced HRCT might 
rather have its strength in early detection and early 
recognition of ILD progression. To evaluate these 
further prospective studies are needed. 
(III) Our findings cannot be transferred easily to 
other diseases with different parenchymal lung 
involvement. SSc patients develop ILD with 
frequent NSIP and less often UIP pattern, and 
in addition have a predominant apico-basal 
distribution. Furthermore it is known that a 
small subgroup of patients with NSIP may have a 
peribronchovascular and upper field distribution 
of lung fibrosis (47). Additionally the incidence 
of a small SSc patient number with organizing 
pneumonia (OP) and combined pulmonary fibrosis 
and emphysema (CPFE) has been reported (48). 
As we could not find such intrapulmonary findings 
in our patient cohort, we were not able to evaluate 
this aspect. Thus, this technique needs validation in 
other diseases and further exploration before it can 
be clinically applied to these conditions.
In conclusion, the reduced HRCT is a robust method 
to assess lung fibrosis in SSc-ILD with minimal dose. In 
contrast to standard HRCT histogram parameters derived 
from the approach of reduced HRCT could discriminate at 
a threshold of 20% lung fibrosis with high sensitivity and 
specificity. Hence it might be used to detect early disease 
progression of lung fibrosis in context of monitoring and 
treatment of SSc patients. It therefore has the potential to 
replace other imaging techniques such as conventional chest 
X-ray and high dose standard HRCT.
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Table S1 Fibrosis severity score (range, 0 to 15*) adapted from 
Camiciottoli et al. (14)
Parenchymal abnormality Score
Ground-glass appearance 1
Irregular pleural margins 2
Septal and subpleural lines 3
Honeycombing 4
Subpleural cysts 5
*, example: in case of presence of all five lung abnormalities all 
scores are summed to an overall score of 15 (score 1 + score 2 + 
score 3 + score 4 + score 5 = overall fibrosis severity score 15).
Table S2 Fibrosis extension score (range, 0 to 24*) adapted from 
Goldin et al. (3)
Upper zone: from apex to upper level of carina
Middle zone: from upper part of carina to division of main lower 
lobe bronchus into segmental bronchi
Lower zone: from the division of main lower lobe bronchus into 
segmental bronchi to the basis of the lung
Scale from 0–4: 0, no fibrosis; 1, 1% to 25%; 2, 26% to 50%; 
3, 51% to 75%; 4, 76% to 100%. *, example: in case of a 
maximum fibrosis score 4 (76% to 100%) in each of the three 
zones of one lung side the scores are summed to an overall 
fibrosis extension score 12, if both lungs would be affect 
symmetrically, the sum of the overall score would be 24.
Supplementary
